A Global, Multicentre, Open-Label, Randomised Phase Ii Trial Of Tobemstomig (Tobe) With Or Without Tiragolumab (Tira) Vs Atezolizumab (Atezo) In Patients (Pts) With Untreated Metastatic Urothelial Cancer (Muc) Ineligible For Platinum-Based Chemotherapy (Chemo)
Tobemstomig;Tiragolumab;Atezolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Global, Multicentre, Open-Label, Randomised Phase Ii Trial Of Tobemstomig (Tobe) With Or Without Tiragolumab (Tira) Vs Atezolizumab (Atezo) In Patients (Pts) With Untreated Metastatic Urothelial Cancer (Muc) Ineligible For Platinum-Based Chemotherapy (Chemo) ### Output: Tobemstomig;Tiragolumab;Atezolizumab